Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: GE HealthCare and Hologic have
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Moon Surgical is aiming to establish a
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The Food and Drug Administration
As we described in a previous article, the Global Cannabis Stock Index rebounded 8.1% in November after a huge October loss. That index is now down 20.1% year-to-date,
Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or the “company”), a biotech company focused on discovery and development of novel psychedelic-derived therapeutics to
– Company speakers include Doug Drysdale, Chief Executive Officer; and Amir Inamdar, MBBS, DNB (Psych), MFPM, Chief Medical Officer – – Featured key opinion leaders
Share this article Novo Nordisk Headquarters in Denmark. Photo: SERGEI GAPON/AFP via Getty Images. Novo Nordisk, manufacturer of blockbuster drugs Ozempic and Wegovy, announced Wednesday
As researchers investigate the potential of psilocybin in cancer patients and LSD as treatment for ADHD, the psychedelic ecosystem witnesses more acquisitions, patents, and decriminalization
Share this article Source: GlobalData, Pharma Intelligence Center, Deals Database (Accessed 22 November 2023) ©GlobalData YTD = year to date Note: Includes all announced and
Share this article Phenomic is making itself heard with two deals in two days to advance cancer cell therapy research. Credit: sanjeri via Getty Images.